Laboratorio Reig Jofre, S.A. (BME:RJF)
Spain · Delayed Price · Currency is EUR 2.730
-0.020 (-0.73%)
Aug 7, 2026, 11:27 AM CET
Laboratorio Reig Jofre Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 332.15 | 331.1 | 338.9 | 316.09 | 271.15 | 236.23 |
Revenue Growth | -0.42% | -2.30% | 7.22% | 16.57% | 14.78% | 2.67% |
Gross Profit Gross Profit Growth | 100.11 | 195.81 | 198.75 | 182.37 | 158.06 | 144.75 |
Operating Income Operating Income Growth | 6.2 | 4.24 | 12.61 | 10.51 | 9.51 | 8.86 |
Net Income Net Income Growth | 3.48 | 5.02 | 10.38 | 9.41 | 8.11 | 5.09 |
Earnings Per Share EPS Growth | 0.04 | 0.06 | 0.13 | 0.12 | 0.10 | 0.07 |
EPS Growth | -45.99% | -53.85% | 8.33% | 20.00% | 42.86% | 0% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Specialty Pharmacare Specialty Pharmacare Growth | 120.03 | 115.26 | - | - | - |
Consumer Healthcare Consumer Healthcare Growth | 74.37 | 72.34 | 59.9 | 54.15 | 47.02 |
Sale of Pharmaceutical Products Sale of Pharmaceutical Products Growth | 136.7 | 151.29 | 244.15 | 217 | 189.21 |
Total Total Growth | 331.1 | 338.9 | 316.09 | 271.15 | 236.23 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 15.11 | 17.01 | 23.96 | 6.49 | 6.9 | 7.22 |
Total Debt Total Debt Growth | 131.28 | 111.61 | 72.38 | 63.25 | 68.81 | 82.13 |
Net Cash (Debt) Net Cash Growth | -116.17 | -94.6 | -48.43 | -56.76 | -61.91 | -74.91 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.43 | -1.16 | -0.60 | -0.71 | -0.78 | -0.96 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1.51 | 1.51 | 31.34 | 19.12 | 16.15 | 0.01 |
Capital Expenditures CapEx Growth | -30.17 | -15.29 | -20.26 | -12.46 | -11.4 | -0.02 |
Free Cash Flow Free Cash Flow Growth | -28.66 | -13.78 | 11.08 | 6.65 | 4.75 | -0 |
Free Cash Flow Growth | - | - | 66.51% | 40.10% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 30.14% | 59.14% | 58.65% | 57.70% | 58.29% | 61.27% |
Operating Margin | 1.87% | 1.28% | 3.72% | 3.33% | 3.51% | 3.75% |
Pretax Margin | 2.28% | 1.91% | 3.49% | 3.32% | 3.23% | 2.45% |
Profit Margin | 2.08% | 1.51% | 3.09% | 2.97% | 2.99% | 2.15% |
FCF Margin | 0.00% | -4.16% | 3.27% | 2.10% | 1.75% | -0.00% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.049 | - | 0.049 | 0.040 | 0.040 | 0.040 |
Dividend Per Share Growth | -51.02% | - | 22.50% | 0% | 0% | -11.11% |
Dividend Yield | 1.79% | 0.02% | 0.01% | 0.02% | 0.03% | 0.00% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 32.28 | 42.83 | 19.15 | 18.75 | 21.90 | 46.57 |
Forward PE | 13.75 | 31.15 | 14.65 | 8.91 | 15.93 | 18.11 |
P/FCF Ratio | - | - | 18.00 | 26.65 | 35.79 | - |
PS Ratio | 0.66 | 0.63 | 0.59 | 0.56 | 0.63 | 1.06 |